Star Health and Allied Insurance Company Limited
NSE:STARHEALTH.NS
466.75 (INR) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 121,727.8 | 120,961.5 | 107,239.659 | 61,691.82 | 55,554.7 | 42,474.19 | 28,875.324 | 20,120.965 | 15,950.721 | 10,691.441 | 7,292.009 | 5,297.367 |
| Cost of Revenue
| -158,800.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 280,528.6 | 120,961.5 | 107,239.659 | 61,691.82 | 55,554.7 | 42,474.19 | 28,875.324 | 20,120.965 | 15,950.721 | 10,691.441 | 7,292.009 | 5,297.367 |
| Gross Profit Ratio
| 2.305 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 276.873 | 126.079 | 417.622 | 316.24 | 234.04 | 210.43 | 55.48 | 25.552 | 451.696 | 3,867.306 | 3,074.476 | 2,776.385 |
| Selling & Marketing Expenses
| 1,999.595 | 1,465.5 | 1,342.16 | 1,359.14 | 1,298.4 | 1,335.83 | 1,093.243 | 603.825 | 469.279 | 569.968 | 180.745 | 359.081 |
| SG&A
| 2,276.468 | 1,465.5 | 1,759.782 | 1,675.38 | 1,532.44 | 1,546.26 | 8,417.426 | 6,190.039 | 5,691.13 | 4,437.274 | 3,255.221 | 3,135.466 |
| Other Expenses
| 142,225.181 | -114,163 | -123,398.73 | -73,543.04 | -52,668.92 | -41,918.22 | -10,027.394 | -7,343.408 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 144,501.649 | -112,697.5 | -121,638.948 | -71,867.66 | -51,136.48 | -40,371.96 | 10,027.394 | 7,343.408 | 14,560.761 | 12,079.84 | 8,225.245 | 6,553.521 |
| Operating Income
| 0 | 8,264 | -14,399.289 | -10,175.84 | 4,418.22 | 2,102.23 | 1,960.48 | 1,247.787 | 1,406.1 | -1,369.633 | -933.236 | -1,256.154 |
| Operating Income Ratio
| 0 | 0.068 | -0.134 | -0.165 | 0.08 | 0.049 | 0.068 | 0.062 | 0.088 | -0.128 | -0.128 | -0.237 |
| Total Other Income Expenses Net
| -105,666.749 | -91,195.899 | -13,966.3 | -14,458.054 | 4,206.435 | -26,121.03 | -18,745.863 | -12,751.489 | -40.341 | -7,654.676 | 0 | 0 |
| Income Before Tax
| 11,288.486 | 8,264 | -13,966.356 | -10,459.5 | 4,134.25 | 1,822.47 | 1,712.035 | 1,179.437 | 1,365.759 | -1,400.509 | -933.236 | -1,256.154 |
| Income Before Tax Ratio
| 0.093 | 0.068 | -0.13 | -0.17 | 0.074 | 0.043 | 0.059 | 0.059 | 0.086 | -0.131 | -0.128 | -0.237 |
| Income Tax Expense
| 2,838.36 | 2,078.1 | -3,559.669 | -2,203.69 | 1,454.23 | 540.21 | 10.487 | -269.162 | -40.341 | -30.876 | 0 | 0 |
| Net Income
| 8,450.126 | 6,185.9 | -10,406.687 | -8,255.81 | 2,680.02 | 1,282.26 | 1,701.548 | 1,179.432 | 1,365.759 | -1,400.509 | -933.236 | -1,256.154 |
| Net Income Ratio
| 0.069 | 0.051 | -0.097 | -0.134 | 0.048 | 0.03 | 0.059 | 0.059 | 0.086 | -0.131 | -0.128 | -0.237 |
| EPS
| 14.48 | 10.7 | -18.65 | -16.54 | 5.49 | 2.23 | 3.73 | 2.77 | 3.68 | -4.13 | -2.82 | -4.47 |
| EPS Diluted
| 14.19 | 10.41 | -18.65 | -16.54 | 5.38 | 2.23 | 3.73 | 2.77 | 3.68 | -4.13 | -2.82 | -4.47 |
| EBITDA
| 12,676.954 | 9,668.888 | -13,049.523 | -9,718.54 | 4,640.439 | 2,383.16 | 2,146.059 | 1,410.339 | -40.341 | -30.876 | 4,036.788 | 0 |
| EBITDA Ratio
| 0.104 | 0.068 | -0.13 | -0.158 | 0.085 | 0.056 | -0.009 | -0.003 | -0.003 | -0.003 | 0 | 0 |